Skip to main content
Lindsay M. Burt
( out of 40 reviews )

Lindsay M. Burt, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track associate professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.

Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.

Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.

Board Certification

American Board of Radiology (Radiation Oncology)

Patient Rating

4.9 /5
( out of 40 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

HUNTSMAN CANCER CENTER

Excellent medical care

HUNTSMAN CANCER CENTER

Dr. Burt was very professional and showed a real concern for me and my health. I welcome such a wonderful concern for me and my health Thank you

HUNTSMAN CANCER CENTER

She is a good doctor

HUNTSMAN CANCER CENTER

Dr. Burt is very professional and it's apparent she cares about my wellbeing. She did an excellent job explaining the procedure and answered all our questions. I highly recommend her as a health professional.

HUNTSMAN CANCER CENTER

Dr. Burt had her resident and nurse speak with us first and then she followed up and explained things more in depth, including showing us my scan and explaining in detail how things would be done through out my course of treatment. She listened intently to all of our questions and concerns all of them, including possible winter weather travel as we live almost 4 hours away in southern Idaho. We were so pleased with her and her staff that it made for a very easy decision for us to choose her and her team to do my radiation treatment with even despite the logistics of having to be in Salt Lake for an extended period of time.

HUNTSMAN CANCER CENTER

Very caring and made sure I understood and she answered my questions in a manner I understood. I have every confidence in her as my Doctor.

HUNTSMAN CANCER CENTER

dr Lindsay Burt was excellent

HUNTSMAN CANCER CENTER

dr Burke is a caring physician. She comes across as a very knowledgeable and very credible radiologist.

HUNTSMAN CANCER CENTER

Very helpful!

Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track associate professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.

Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.

Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.

Board Certification and Academic Information

Academic Departments Radiation Oncology -Associate Professor (Clinical)
Board Certification
American Board of Radiology (Radiation Oncology)

Education history

Undergraduate Chemical Engineering with Biomedical specialization - Willamette University
Undergraduate Boise State University, Honors College
Undergraduate Biology-Chemistry - Claremont McKenna College B.A.
Professional Medical Medicine - University of Utah School of Medicine M.D.
Internship Transitional Year - Sacred Heart Medical Center Transitional Internship
Residency Radiation Oncology - University of Utah, Huntsman Cancer Hospital Resident
Chief Resident Radiation Oncology - University of Utah, Huntsman Cancer Hospital Chief Resident
Certification Health Science Leadership Program - University of Utah David Ecceles School of Business Certification
Certification Quality Improvement - University of Utah Certification

Selected Publications

Journal Article

  1. Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2020). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42.
  2. Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL (2021). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Res Treat, 187(1), 287-294.
  3. Mattes MD, Patel KR, Burt LM, Hirsch AE (2016). A Nationwide Medical Student Assessment of Oncology Education. J Cancer Educ, 31(4), 679-686.
  4. Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol, 28(6), 377-384.
  5. McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2020). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92.
  6. Burt LM, Shrieve DC, Tward JD (2014). Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys, 88(1), 94-100.
  7. Nabavizadeh N, Burt LM, Mancini BR, Morris ZS, Walker AJ, Miller SM, Bhavsar S, Mohindra P, Kim MB, Kharofa J (2016). Results of the 2013-2015 Association of Residents in Radiation Oncology Survey of Chief Residents in the United States. Int J Radiat Oncol Biol Phys, 94(2), 228-34.
  8. Verma V, Burt L, Gimotty PA, Ojerholm E (2016). Contemporary Trends in Radiation Oncology Resident Research. Int J Radiat Oncol Biol Phys, 96(4), 915-918.
  9. Burt LM, Trifiletti DM, Nabavizadeh N, Katz LM, Morris ZS, Royce TJ (2017). Supply and Demand for Radiation Oncology in the United States: A Resident Perspective. Int J Radiat Oncol Biol Phys, 97(2), 225-227.
  10. Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50.
  11. Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman H (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial. J Neurooncol, 148(3), 577-585.
  12. Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt LM (2021). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. J Neurooncol, 151(2), 93-101.
  13. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017). Adjuvant radiotherapy for atypical meningiomas. J Neurosurg, 126(6), 1822-1828.
  14. Ager BJ, Christensen MT, Burt LM, Poppe M (2019). The value of high-dose radiotherapy in intracranial ependymoma. Pediatric blood & cancer, 66(6), e27697.
  15. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney D (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast (Edinburgh, Scotland), 35, 122-129.
  16. Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen R (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World neurosurgery, 86, 210-9.
  17. Burt LM, Orlandi RR, Hunt JP, Buchmann LO, Grossmann KF, Monroe MM, Shrieve DC, Hitchcock (2016). Function Preservation and Optimal Outcomes ¿ Definitive Chemoradiotherapy with Multi-phase Treatment Planning for Locally Advanced Sinonasal Cancer. Journal of radiation oncology, 5(1), 47-54.
  18. Burt LM, Poppe MM., Kokeny KE., Gaffney DK, Shrieve DC., Tward J (2016). Comparison of Treatments for Breast Cancer Arising after Radiation Treatment for Hodgkin's Lymphoma. Journal of radiation oncology, 6(1), 65-72.
  19. Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney D (2017). Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Advances in radiation oncology, 2(2), 235-243.
  20. Burt LM, Shrieve DC, Tward J (2018). Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. Advances in radiation oncology, 3(2), 170-180.
  21. Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri (2020). Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO clinical cancer informatics, 4, 794-798.
  22. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney D (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO global oncology, 7, 173-182.
  23. Hsieh K, Housri N, Haffty B, Smith B, Burt L (2021). Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy. Clinical breast cancer, 21(5), 408-416.
  24. Kundu B, Brock AA, Garry JG, Jensen RL, Burt LM, Cannon DM, Shrieve DC, Rolston J (2022). Outcomes using linear accelerator stereotactic radiosurgery for the treatment of trigeminal neuralgia: A single-center, retrospective study. Surgical neurology international, 13, 246.
  25. Kraus RD, Weil CR, Frances Su FC, Cannon DM, Burt LM, Mendez J (2022). Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients. Neuro-oncology practice, 9(5), 380-389.
  26. Peterson JS, Peckham ME, Poppe MM, Burt LM, Shrieve DC, Cannon D (2022). Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Advances in radiation oncology, 7(5), 100994.
  27. Hutten RJ,Fenlon JB,Kessel AC,Straessler KM,Huang YJ,Gaffney DK,Suneja G,Zempolich K,Burt L (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy,
  28. Harris K,Vanderhooft L,Burt L,Vanderhooft S,Hull (2012). Tanning business practices in Salt Lake County, Utah. Journal of the American Academy of Dermatology, 66(3), 513-514.
  29. Weil CR, Lew FH, Williams VM, Burt LM, Ermoian RP, Poppe M (2022). Patterns of Care and Utilization Disparities in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Advances in radiation oncology, 7(6), 100868.
  30. Kunz JN, Huang YJ, Casper AC, Suneja G, Burt LM, Jhingran A, Joyner MM, Harkenrider MM, Small W Jr, Grant JD, Kidd EA, Boucher K, Gaffney D (2023). Dosimetric Evaluation of Organs at Risk From SAVE Protocol. International journal of radiation oncology, biology, physics,
  31. Lindsay M Burt, Yuji Chen, Alison Fraser, John Snyder, Vikrant Deshmukh, Michael Newman, Paul Thielking, David Gaffney, Mia Hashibe (2023). Development of mental health disorders in endometrial cancer survivors and the impact on overall survival—a population-based cohort study. European Journal of Gynaecological Oncology, 44(1), 51-61.
  32. Christopher R. Weil, Fadi Haroun, Kevin Guo, Ryan D. Kraus, Zhao Hui, Lindsay M. Burt, Gita Suneja, Cristina M. Decesaris, Y. Jessica Huang, David K. Gaffne (2023). Importance of radiographic tumor regression during radiotherapy in squamous cell versus adenocarcinoma of the uterine cervix as assessed by MRI and cone beam CT. European Journal of Gynaecological Oncology, 44(1), 68-78.
  33. Jessica Kunzman, Ryan Hutten, Kristen Kelley, Kate Harris, David K. Gaffney, Cristina Decesaris, Gita Suneja, Lindsay M. Burt (2023). Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study. European Journal of Gynaecological Oncology, 44(2), 25 - 31.
  34. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney D (2023). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34.
  35. Gravbrot N, Rock CB, Weil CR, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2024). Gross tumor and intracranial control benefits with fractionated radiotherapy compared to stereotactic radiosurgery for patients with WHO grade 2 meningioma. World neurosurgery,
  36. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. European journal of cancer (Oxford, England, 201, 113913.
  37. Rock CB, Weil CR, Rock CB, Gravbrot N, Burt LM, DeCesaris C, Menacho ST, Jensen RL, Shrieve DC, Cannon D (2024). Patterns of failure after radiosurgery for WHO grade 1 or imaging defined meningiomas: Long-term outcomes and implications for management. Journal of clinical neuroscience, 120, 175-180.
  38. Cole KL, Earl ER, Findlay MC, Sherrod BA, Tenhoeve SA, Kunzman J, Cannon DM, Akerley W, Burt L, Seifert SB, Goldman M, Jensen R (2024). Assessing Survival in Non-Small Cell Lung Cancer Brain Metastases After Stereotactic Radiosurgery: Before and After the Start of the Targetable Mutation Era. Journal of neuro-oncology,
  39. Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman (2024). Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Neuro-oncology advances, 6(1), vdae202.
  40. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney (2024). Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Practical radiation oncology, 14(6), e500-e506.
  41. DeCesaris C, Bedell S, Kelley K, Gaffney D, Suneja G, Burt L, Jarboe E, Brower (2024). Use of Radiation Therapy in the Management of Vulvar Cancers-Identification and Management of Acute and Late Toxicities. Practical radiation oncology, 15(1), e57-e62.
  42. Burt L, Jarboe E, Gaffney D, Suneja G, DeCesaris C, Bedell S, Brower (2024). Vulvar Cancer: Histopathologic Considerations and Nuances to Management: Vulvar cancer considerations and nuances. Practical radiation oncology, 15(1), 86-92.
  43. Cole KL, Earl ER, Findlay MC, Sherrod BA, Tenhoeve SA, Kunzman J, Cannon DM, Akerley W, Burt L, Seifert SB, Goldman M, Jensen R (2024). Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era. Journal of neuro-oncology, 169(3), 671-681.
  44. Cruttenden J, Grant J, Evans J, Cannon G, Gaffney DK, Poppe M, Burt LM, Avizonis V, Boothe (2025). Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer. American journal of clinical oncology, 48(5), 222-229.
  45. Hutten RJ, Fenlon JB, Kessel AC, Straessler KM, Huang YJ, Gaffney DK, Suneja G, Zempolich K, Burt L (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, 21(6), 764-768.
  46. Cruttenden J, Weil C, Byer D, Burt L, Suneja G, Gaffney D, DeCesaris (2024). Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis. Advances in radiation oncology, 10(2), 101698.
  47. Weil CR, Rock CB, Sarkar V, Gravbrot N, Lew FH, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon D (2025). Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas. American journal of clinical oncology, 48(8), 403-409.
  48. Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. International journal of radiation oncology, biology, physics, 123(1), 141-149.
  49. DeCesaris C, Bedell S, Gaffney D, Suneja G, Burt L, Brower (2025). Identification and Management of Late toxicities after Radiotherapy for Vulvar Cancer. Practical radiation oncology,

Review

  1. Parsons MW, Huang YJ, Burt L, Suneja G, Gaffney (2022). Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation. International journal of gynecological cancer, 32(3), 311-315.
  2. Tao R,Lloyd S,Burt L,Whisenant J,Garrido-Laguna I,Das (2017). Pelvic Reirradiation for the Treatment of Locally Recurrent Rectal Cancer. Current colorectal cancer reports, 13(2), 175-182.

Book Chapter

  1. Burt LM,Suneja G,Shrieve D (2018). Pituitary adenoma. Adult CNS Radiation Oncology: Principles and Practice, 19-35.

Letter

  1. Harris K, Vanderhooft L, Burt L, Vanderhooft S, Hull C (2012). Tanning business practices in Salt Lake County, Utah. [Letter to the editor]. J Am Acad Dermatol, 66(3), 513-4.
  2. Burt L, Gaffney (2024). Take Your Best Shot Upfront!. International journal of radiation oncology, biology, physics, 118(2), 319-320.

Other

  1. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney D (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecologic oncology, 162(2), 454-460.
  2. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. European journal of cancer (Oxford, England, 202, 114017.